Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    63,900.28
    -2,450.81 (-3.69%)
     

  • CMC Crypto 200

    1,363.60
    -18.98 (-1.37%)
     

  • FTSE 100

    8,089.15
    +48.77 (+0.61%)
     

  • Gold

    2,337.60
    -0.80 (-0.03%)
     

  • Crude Oil

    82.71
    -0.10 (-0.12%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Company News for Feb 27, 2020

Zacks Equity Research
·1-min read

  • Shares of Novavax, Inc. NVAX surged 16% after the late-stage biotechnology company highlighted progress in efforts to develop novel vaccine to shield against coronavirus.

  • Shares of B&G Foods, Inc. BGS gained 23.2% after the company reported adjusted earnings of 28 cents per share, which were in line with the Zacks Consensus Estimate.

  • Shares of Sabre Corporation SABR declined 16.1% after the company reported quarterly earnings of $0.16 per share, which missed the Zacks Consensus Estimate of $0.17.

  • Shares of Chesapeake Energy Corporation CHK declined 30.5% after the company reported revenues of $969 million, which missed the Zacks Consensus Estimate of $1,212 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chesapeake Energy Corporation (CHK) : Free Stock Analysis Report
 
Novavax, Inc. (NVAX) : Free Stock Analysis Report
 
B&G Foods, Inc. (BGS) : Free Stock Analysis Report
 
Sabre Corporation (SABR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research